참고문헌 (123)

1. Tang W Morgan DR Meyers MO Dominguez RL Martinez E Kakudo K Epstein–Barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile Infect Agent Cancer 2012 7 21 22929309 

   상세보기

2. Hardbower DM Peek RM Jr Wilson KT At the bench: Helicobacter pylori , dysregulated host responses, DNA damage, and gastric cancer J Leukocyte Biol 2014 96 201 212 24868089 

3. Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 2010 127 2893 2917 21351269 

   상세보기

4. Jemal A Bray F Center MM Ferlay J Ward E Forman D Global cancer statistics CA Cancer J Clin 2011 61 69 90 21296855 

5. Kuo HY Yeh KH Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review Anticancer Res 2014 34 3695 3699 24982389 

   상세보기

6. Kasper S Schuler M Targeted therapies in gastroesophageal cancer Eur J Cancer 2014 50 1247 1258 24495747 

   상세보기

7. Kim C Mulder K Spratlin J How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer Oncologist 2014 19 1046 1055 25142842 

   상세보기

8. Fassan M Simbolo M Bria E Mafficini A Pilotto S Capelli P High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers Gastric Cancer 2014 17 442 449 24272205 

   상세보기

9. Wadhwa R Song S Lee JS Yao Y Wei Q Ajani JA Gastric cancer—molecular and clinical dimensions Nat Rev Clin Oncol 2013 10 643 655 24061039 

   상세보기

10. Cancer Genome Atlas Research Network Comprehensive molecular characterization of gastric adenocarcinoma Nature 2014 513 202 209 25079317 

11. Tsai KW Liao YL Wu CW Hu LY Li SC Chan WC Aberrant expression of miR-196a in gastric cancers and correlation with recurrence Genes Chromosomes Cancer 2012 51 394 401 22420029 

    상세보기

12. Lo SS Hung PS Chen JH Tu HF Fang WL Chen CY Overexpression of miR-370 and downregulation of its novel target TGFbeta-RII contribute to the progression of gastric carcinoma Oncogene 2012 31 226 237 21666718 

13. Oh HK Tan AL Das K Ooi CH Deng NT Tan IB Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer Clin Cancer Res 2011 17 2657 2667 21415212 

    상세보기

14. Ueda T Volinia S Okumura H Shimizu M Taccioli C Rossi S Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis Lancet Oncol 2010 11 136 146 20022810 

    상세보기

15. Suzuki H Yamamoto E Nojima M Kai M Yamano HO Yoshikawa K Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect Carcinogenesis 2010 31 2066 2073 20924086 

    상세보기

16. Yao Y Suo AL Li ZF Liu LY Tian T Ni L MicroRNA profiling of human gastric cancer Mol Med Rep 2009 2 963 970 21475928 

17. Guo J Miao Y Xiao B Huan R Jiang Z Meng D Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues J Gastroenterol Hepatol 2009 24 652 657 19175831 

    상세보기

18. Zhang Z Li Z Gao C Chen P Chen J Liu W miR-21 plays a pivotal role in gastric cancer pathogenesis and progression Lab Invest 2008 88 1358 1366 18794849 

    상세보기

19. Qu Y Dang S Hou P Gene methylation in gastric cancer Clin Chim Acta 2013 424 53 65 23669186 

    상세보기

20. Li L Su X Choi GC Cao Y Ambinder RF Tao Q Methylation profiling of Epstein–Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins BMC Cancer 2012 12 125 22458933 

    상세보기

21. Zouridis H Deng N Ivanova T Zhu Y Wong B Huang D Methylation subtypes and large-scale epigenetic alterations in gastric cancer Sci Transl Med 2012 4 156ra140 

22. Loh M Liem N Vaithilingam A Lim PL Sapari NS Elahi E DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach BMC Gastroenterol 2014 14 55 24674026 

23. Geddert H Zur Hausen A Gabbert HE Sarbia M EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1 Anal Cell Pathol (Amst) 2010 33 143 149 20978327 

    상세보기

24. Chang MS Uozaki H Chong JM Ushiku T Sakuma K Ishikawa S CpG island methylation status in gastric carcinoma with and without infection of Epstein–Barr virus Clin Cancer Res 2006 12 2995 3002 16707594 

    상세보기

25. Yang P Wang Y Chen J Li H Kang L Zhang Y RCOR2 is a subunit of the LSD1 complex that regulates ESC property and substitutes for SOX2 in reprogramming somatic cells to pluripotency Stem Cells 2011 29 791 801 21433225 

    상세보기

26. Suva ML Rheinbay E Gillespie SM Patel AP Wakimoto H Rabkin SD Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells Cell 2014 157 580 594 24726434 

    상세보기

27. Zhao J Liang Q Cheung KF Kang W Lung RW Tong JH Genome-wide identification of EpsteinBarr virus-driven promoter methylation profiles of human genes in gastric cancer cells Cancer 2013 119 304 312 22833454 

28. Liang Q Yao X Tang S Zhang J Yau TO Li X Integrative identification of Epstein–Barr virus-associated mutations and epigenetic alterations in gastric cancer Gastroenterology (e-pub ahead of print 27 August 2014; doi: 10.1053/j.gastro.2014.08.036 

    상세보기

29. Woellmer A Hammerschmidt W Epstein–Barr virus and host cell methylation: regulation of latency, replication and virus reactivation Curr Opin Virol 2013 3 260 265 23567077 

    상세보기

30. Niller HH Tarnai Z Decsi G Zsedenyi A Banati F Minarovits J Role of epigenetics in EBV regulation and pathogenesis Fut Microbiol 2014 9 747 756 

31. Okada T Nakamura M Nishikawa J Sakai K Zhang Y Saito M Identification of genes specifically methylated in Epstein–Barr virus-associated gastric carcinomas Cancer Sci 2013 104 1309 1314 23829175 

    상세보기

32. Ryan JL Jones RJ Kenney SC Rivenbark AG Tang W Knight ER Epstein–Barr virus-specific methylation of human genes in gastric cancer cells Infect Agent Cancer 2010 5 27 21194482 

    상세보기

33. Matsusaka K Funata S Fukayama M Kaneda A DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein–Barr virus World J Gastroenterol 2014 20 3916 3926 24744581 

34. Lin J Gilbert J Rudek MA Zwiebel JA Gore S Jiemjit A A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors Clin Cancer Res 2009 15 6241 6249 19789320 

    상세보기

35. Kenney SC Mertz JE Regulation of the latent-lytic switch in Epstein–Barr virus Semin Cancer Biol 2014 26 60 68 24457012 

    상세보기

36. Tikhmyanova N Schultz DC Lee T Salvino JM Lieberman PM Identification of a new class of small molecules that efficiently reactivate latent Epstein–Barr virus ACS Chem Biol 2014 9 785 795 24028149 

37. Westphal EM Blackstock W Feng W Israel B Kenney SC Activation of lytic Epstein–Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo : a potential method for treating EBV-positive malignancies Cancer Res 2000 60 5781 5788 11059774 

    상세보기

38. Ghosh SK Perrine SP Williams RM Faller DV Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents Blood 2012 119 1008 1017 22160379 

    상세보기

39. Doolittle JM Webster-Cyriaque J Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesis MBio 2014 5 e01015 14 24781742 

40. Perrine SP Hermine O Small T Suarez F O'Reilly R Boulad F A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein–Barr virus-associated lymphoid malignancies Blood 2007 109 2571 2578 17119113 

    상세보기

41. Wildeman MA Novalic Z Verkuijlen SA Juwana H Huitema AD Tan IB Cytolytic virus activation therapy for Epstein–Barr virus-driven tumors Clin Cancer Res 2012 18 5061 5070 22761471 

    상세보기

42. Gulley ML Tang W Using Epstein–Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder Clin Microbiol Rev 2010 23 350 366 20375356 

    상세보기

43. Heslop HE Combining drugs and biologics to treat nasopharyngeal cancer Mol Ther 2014 22 8 9 24384910 

    상세보기

44. Fukayama M Hino R Uozaki H Epstein–Barr virus and gastric carcinoma: virus–host interactions leading to carcinoma Cancer Sci 2008 99 1726 1733 18616681 

    상세보기

45. Ocean AJ Christos P Sparano JA Shah MA Yantiss RK Cheng J Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach Invest New Drugs 2014 32 542 548 24526575 

    상세보기

46. Hui KF Lam BH Ho DN Tsao SW Chiang AK Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein–Barr virus Mol Cancer Ther 2013 12 747 758 23475956 

    상세보기

47. Onoyama M Kitadai Y Tanaka Y Yuge R Shinagawa K Tanaka S Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer Neoplasia 2013 15 1391 1399 24403861 

48. Fu DX Tanhehco Y Chen J Foss CA Fox JJ Chong JM Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors Nat Med 2008 14 1118 1122 18776891 

    상세보기

49. Gressette M Verillaud B Jimenez-Pailhes AS Lelievre H Lo KW Ferrand FR Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis -platin and radiotherapy on patient-derived xenografts PLoS ONE 2014 9 e91325 24618637 

    상세보기

50. Yang X Dai W Kwong DL Szeto CY Wong EH Ng WT Epigenetic markers for non-invasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting Int J Cancer (e-pub ahead of print 8 September 2014; doi: 10.1002/ijc.29192 

    상세보기

51. Ahn SM Chan JY Zhang Z Wang H Khan Z Bishop JA Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer JAMA Otolaryngol Head Neck Surg 2014 140 846 854 25078109 

    상세보기

52. Couraud S Vaca-Paniagua F Villar S Oliver J Schuster T Blanche H Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free dna in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002 Clin Cancer Res 2014 20 4613 4624 25013125 

    상세보기

53. Li X Zhou F Jiang C Wang Y Lu Y Yang F Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis PLoS ONE 2014 9 e103162 25050929 

    상세보기

54. Hoadley KA Yau C Wolf DM Cherniack AD Tamborero D Ng S Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin Cell 2014 158 929 944 25109877 

    상세보기

55. Lee J van Hummelen P Go C Palescandolo E Jang J Park HY High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma PLoS ONE 2012 7 e38892 22723903 

    상세보기

56. Tapia O Riquelme I Leal P Sandoval A Aedo S Weber H The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance Virchows Arch 2014 465 25 33 24844205 

57. Matsuoka T Yashiro M The role of PI3K/Akt/mTOR signaling in gastric carcinoma Cancers (Basel) 2014 6 1441 1463 25003395 

    상세보기

58. Xing X Zhang L Wen X Wang X Cheng X Du H PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway Anticancer Drugs 2014 25 1129 1140 25035961 

    상세보기

59. Zhang C Awasthi N Schwarz MA Schwarz RE The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer Int J Oncol 2013 43 1627 1635 24042258 

    상세보기

60. Wong CH Loong HH Hui CW Lau CP Hui EP Ma BB Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma Invest New Drugs 2013 31 1399 1408 23975511 

    상세보기

61. Robles AI Harris CC Clinical outcomes and correlates of TP53 mutations and cancer Cold Spring Harb Perspect Biol 2010 2 a001016 20300207 

    상세보기

62. Fels Elliott DR Fitzgerald RC Molecular markers for Barrett's esophagus and its progression to cancer Curr Opin Gastroenterol 2013 29 437 445 23689523 

    상세보기

63. Shimizu T Marusawa H Matsumoto Y Inuzuka T Ikeda A Fujii Y Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection Gastroenterology 2014 147 407 417 e3 24786892 

64. Lee JH Kim SH Han SH An JS Lee ES Kim YS Clinicopathological and molecular characteristics of Epstein–Barr virus-associated gastric carcinoma: a meta-analysis J Gastroenterol Hepatol 2009 24 354 365 19335785 

    상세보기

65. Strong MJ Xu G Coco J Baribault C Vinay DS Lacey MR Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy PLoS Pathogen 2013 9 e1003341 23671415 

66. NCCN National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer, version 1.2014. Available at http://www.nccn.org accessed 10 May 2014. 

67. Liguigli W Tomasello G Toppo L Ratti M Passalacqua R Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial Fut Oncol 2014 10 1549 1557 

68. Lee J Ou SH Towards the goal of personalized medicine in gastric cancer—time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway Discov Med 2013 16 7 14 23911227 

    상세보기

69. Yamamoto H Watanabe Y Maehata T Morita R Yoshida Y Oikawa R An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa World J Gastroenterol 2014 20 3927 3937 24744582 

70. Ott PA Hodi FS Robert C CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients Clin Cancer Res 2013 19 5300 5309 24089443 

    상세보기

71. Chen BJ Chapuy B Ouyang J Sun HH Roemer MG Xu ML PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies Clin Cancer Res 2013 19 3462 3473 23674495 

    상세보기

72. Wang W Sun J Li F Li R Gu Y Liu C A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding Hum Mutat 2012 33 480 484 22190470 

73. Yoda Y Takeshima H Niwa T Kim JG Ando T Kushima R Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer Gastric Cancer 2014 

74. Lee J Ou SH Towards the goal of personalized medicine in gastric cancer—time to move beyond HER2 inhibition. Part I: Targeting receptor tyrosine kinase gene amplification Discov Med 2013 15 333 341 23819947 

    상세보기

75. Periasamy J Muthuswami M Rao DB Tan P Ganesan K Stratification and delineation of gastric cancer signaling by in vitro transcription factor activity profiling and integrative genomics Cell Signal 2014 26 880 894 24462706 

    상세보기

76. Nagarajan N Bertrand D Hillmer AM Zang ZJ Yao F Jacques PE Whole-genome reconstruction and mutational signatures in gastric cancer Genome Biol 2012 13 R115 23237666 

77. Lei Z Tan IB Das K Deng N Zouridis H Pattison S Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil Gastroenterology 2013 145 554 565 23684942 

78. Thiem S Pierce TP Palmieri M Putoczki TL Buchert M Preaudet A mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice J Clin Invest 2013 123 767 781 23321674 

    상세보기

79. Wang K Yuen ST Xu J Lee SP Yan HH Shi ST Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer Nat Genet 2014 46 573 582 24816253 

    상세보기

80. Zhou J Hayakawa Y Wang TC Bass AJ RhoA mutations identified in diffuse gastric cancer Cancer Cell 2014 26 9 11 25026207 

    상세보기

81. Kale VP Hengst JA Desai DH Dick TE Choe KN Colledge AL A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion Cancer Lett 2014 354 299 310 25172415 

    상세보기

82. Tao J Deng NT Ramnarayanan K Huang B Oh HK Leong SH CD44-SLC1A2 gene fusions in gastric cancer Sci Transl Med 2011 3 77ra30 

83. Lee J Lee SE Kang SY Do IG Lee S Ha SY Identification of ROS1 rearrangement in gastric adenocarcinoma Cancer 2013 119 1627 1635 23400546 

84. Abel HJ Al-Kateb H Cottrell CE Bredemeyer AJ Pritchard CC Grossmann AH Detection of gene rearrangements in targeted clinical next-generation sequencing J Mol Diagn 2014 16 405 417 24813172 

85. Yamamoto T Iwatsuki K Diversity of Epstein–Barr virus Bam HI-A rightward transcripts and their expression patterns in lytic and latent infections J Med Microbiol 2012 61 1445 1453 22700548 

    상세보기

86. Hino R Uozaki H Murakami N Ushiku T Shinozaki A Ishikawa S Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma Cancer Res 2009 69 2766 2774 19339266 

    상세보기

87. Quinn LL Zuo J Abbott RJ Shannon-Lowe C Tierney RJ Hislop AD Cooperation between Epstein–Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle PLoS Pathogen 2014 10 e1004322 25144360 

88. Griffin BD Gram AM Mulder A Van Leeuwen D Claas FH Wang F EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail J Immunol 2013 190 1672 1684 23315076 

    상세보기

89. Lung RW Tong JH To KF Emerging roles of small Epstein–Barr virus derived non-coding RNAs in epithelial malignancy Int J Mol Sci 2013 14 17378 17409 23979421 

90. Marquitz AR Mathur A Chugh PE Dittmer DP Raab-Traub N Expression profile of microRNAs in Epstein–Barr virus-infected AGS gastric carcinoma cells J Virol 2014 88 1389 1393 24227849 

    상세보기

91. Marquitz AR Mathur A Shair KH Raab-Traub N Infection of Epstein–Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression Proc Natl Acad Sci USA 2012 109 9593 9598 22647604 

    상세보기

92. Gulley ML Tang W Laboratory assays for Epstein–Barr virus-related disease J Mol Diagn 2008 10 279 292 18556771 

93. Gulley ML Pulitzer DR Eagan PA Schneider BG Epstein–Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation Hum Pathol 1996 27 20 27 8543306 

    상세보기

94. Kim L Kim JM Hur YS Shin YW Park IS Choi SJ Extended gastritis cystica profunda associated with Epstein–Barr virus-positive dysplasia and carcinoma with lymphoid stroma Pathol Int 2012 62 351 355 22524666 

    상세보기

95. Schetter AJ You WC Lennette ET Gail MT Rabkin CS Association of Epstein–Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort Cancer Sci 2008 99 350 354 18201267 

    상세보기

96. Zur Hausen A van Rees BP van Beek J Craanen ME Bloemena E Offerhaus GJ Epstein–Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis J Clin Pathol 2004 57 487 491 15113855 

    상세보기

97. Cheng N Hui DY Liu Y Zhang NN Jiang Y Han J Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms Gastric Cancer 2014 

98. Chen JN Jiang Y Li HG Ding YG Fan XJ Xiao L Epstein–Barr virus genome polymorphisms of Epstein–Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma Virus Res 2011 160 191 199 21723347 

99. Tsai MH Raykova A Klinke O Bernhardt K Gartner K Leung CS Spontaneous lytic replication and epitheliotropism define an Epstein–Barr virus strain found in carcinomas Cell Rep 2013 5 458 470 24120866 

    상세보기

100. Hutajulu SH Hoebe EK Verkuijlen SA Fachiroh J Hariwijanto B Haryana SM Conserved mutation of Epstein–Barr virus-encoded Bam HI-A rightward frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma Infect Agent Cancer 2010 5 16 20849661 

     상세보기

101. Carneiro F Seixas M Sobrinho-Simoes M New elements for an updated classification of the carcinomas of the stomach Pathol Res Pract 1995 191 571 584 7479380 

     상세보기

102. Ryan JL Morgan DR Dominguez RL Thorne LB Elmore SH Mino-Kenudson M High levels of Epstein–Barr virus DNA in latently infected gastric adenocarcinoma Lab Invest 2009 89 80 90 19002111 

     상세보기

103. Al-Batran SE Werner D Recent advances and future trends in the targeted therapy of metastatic gastric cancer Expert Rev Gastroenterol Hepatol 2014 8 555 569 24665840 

104. Anonymous University of North Carolina Hospitals McLendon Clinical Laboratories. Available at https://labs.unchealthcare.org/directory/molecular_pathology accessed 10 May 2014. 

105. Funkhouser WK Jr. Lubin IM Monzon FA Zehnbauer BA Evans JP Ogino S Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology J Mol Diagn 2012 14 91 103 22260991 

106. Pritchard CC Smith C Salipante SJ Lee MK Thornton AM Nord AS ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing J Mol Diagn 2012 14 357 366 22658618 

107. Salipante SJ Scroggins SM Hampel HL Turner EH Pritchard CC Microsatellite instability detection by next generation sequencing Clin Chem 2014 60 1192 1199 24987110 

     상세보기

108. Perez-Cabornero L Infante M Velasco E Lastra E Miner C Duran M Evaluating the effect of unclassified variants identified in MMR genes using phenotypic features, bioinformatics prediction, and RNA assays J Mol Diagn 2013 15 380 390 23523604 

109. McLean MH El-Omar EM Genetics of gastric cancer Nat Rev Gastroenterol Hepatol 2014 11 664 674 25134511 

     상세보기

110. Shi L Campbell G Jones WD Campagne F Wen Z Walker SJ The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Nat Biotechnol 2010 28 827 838 20676074 

     상세보기

111. Tang W Hu Z Muallem H Gulley ML Quality assurance of RNA expression profiling in clinical laboratories J Mol Diagn 2012 14 1 11 22020152 

112. Li S Tighe SW Nicolet CM Grove D Levy S Farmerie W Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study Nat Biotechnol 2014 32 915 925 25150835 

     상세보기

113. SEQC/MAQC-III Consortium A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium Nat Biotechnol 2014 32 903 914 25150838 

     상세보기

114. Cottrell CE Al-Kateb H Bredemeyer AJ Duncavage EJ Spencer DH Abel HJ Validation of a next-generation sequencing assay for clinical molecular oncology J Mol Diagn 2014 16 89 105 24211365 

115. Pritchard CC Salipante SJ Koehler K Smith C Scroggins S Wood B Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens J Mol Diagn 2014 16 56 67 24189654 

116. Cheng DT Cheng J Mitchell TN Syed A Zehir A Mensah NY Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data J Mol Diagn 2014 16 504 518 25017477 

117. Robb JA Gulley ML Fitzgibbons PL Kennedy MF Cosentino LM Washington K A call to standardize preanalytic data elements for biospecimens Arch Pathol Lab Med 2014 138 526 537 23937609 

     상세보기

118. Korlimarla A Prabhu JS Anupama CE Remacle J Wahi K Sridhar TS Separate quality-control measures are necessary for estimation of RNA and methylated DNA from formalin-fixed, paraffin-embedded specimens by quantitative PCR J Mol Diagn 2014 16 253 260 24412525 

119. Jennings L Van Deerlin VM Gulley ML Recommended principles and practices for validating clinical molecular pathology tests Arch Pathol Lab Med 2009 133 743 755 19415949 

     상세보기

120. Aziz N Zhao Q Bry L Driscoll DK Funke B Gibson JS College of American Pathologists' Laboratory Standards for next-generation sequencing clinical tests Arch Pathol Lab Med 2014 

121. Gargis AS Kalman L Berry MW Bick DP Dimmock DP Hambuch T Assuring the quality of next-generation sequencing in clinical laboratory practice Nat Biotechnol 2012 30 1033 1036 23138292 

     상세보기

122. Rehm HL Bale SJ Bayrak-Toydemir P Berg JS Brown KK Deignan JL ACMG clinical laboratory standards for next-generation sequencing Genet Med 2013 15 733 747 23887774 

     상세보기

123. Schrijver I Aziz N Farkas DH Furtado M Gonzalez AF Greiner TC Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology J Mol Diagn 2012 14 525 540 22918138